The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorThe University of Texas Health Science Center, Houston

About this trial

To establish a clinical registry of suspected cases of AFE. The existing registry will be migrated to a new platform,

Eligibility criteria

Qualifiers

All subjects or their next of kin must be able to provide a signed and dated informed consent form.

In the case of lethal AFE, the surviving family member or next of kin must be able to provide a signed and dated informed consent form with an accompanying death certificate and proof of legal kinship.

Participants are expected to be willing to permit collection of data about their affected pregnancy, previous and future pregnancies, and their current and future health conditions.

Providing biological samples is not required for enrollment.

Disqualifiers

The inability of an individual to provide a signed and dated informed consent form or those who do not wish to participate.

Trial design

Treatments tested in this trial

  • Patient

Treatment groups

400 Participants
are divided into 1 treatment group

Sponsors and collaborators

The University of Texas Health Science Center, Houston

Lead sponsor

Amniotic Fluid Embolism (AFE) Foundation

Collaborator